Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment

Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment by Xiaohu Zheng https://t.co/f3mfnm7mng

New research: Organ-Specific Immune-Related Adverse Events for PD-1 Antibodies in Lung Cancer Treatment: Anti-PD-1 therapy has revolutionized the clinical treatment of lung cancer. With the increasing number of lung cancer patients being… https://t.co/YWGx